Home
Scholarly Works
Risk of inhibitor development in previously...
Conference

Risk of inhibitor development in previously treated patients with positive inhibitor history or low titer of inhibitor at baseline: results of a survey of hemophilia experts

Authors

Marcucci M; Fisher K; Kenet G; Young G; Walker I; Thabane L; Iorio A

Volume

12

Pagination

pp. 34-34

Publisher

WILEY-BLACKWELL

Publication Date

June 1, 2014

Conference proceedings

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

ISSN

1538-7933

Contact the Experts team